Stryker

Stryker

Yahoo Finance • 3 hours ago

What 3.4% GDP Growth and a 4.2% Jobless Rate Say About a Hard Day on Wall Street

WASHINGTON, Nov. 5, 2026 /PRNewswire/ -- American News Group News Commentary - U.S. stocks were sharply lower on Thursday morning. As of 11:02 a.m. ET, the S&P 500 was down 3.39% at 7,427.97, the Nasdaq Composite was down 5.08% at 24,430.2... Full story

Yahoo Finance • 6 days ago

Stryker's Q3 Miss Expected, But Negative Tone on Underperformance Unexpected, Truist Says

Stryker's (SYK) Q3 miss and lower guidance were anticipated, but its comments about underperformance Keep reading this article with Yahoo Finance Plus Silver Upgrade to Silver Silver Premium news Full access to Financial Times and MT N... Full story

Yahoo Finance • 7 days ago

Stryker anticipates 6.5% to 7% organic net sales growth in 2026 as it plans to scale Versius in the U.S.

Earnings Call Insights: Stryker (SYK) Q3 2026 MANAGEMENT VIEW * "Organic sales growth for the quarter was 7.7% with 9.1% growth in MedSurg and Neurotechnology and 5.9% growth in Orthopaedics." (Chairman & CEO Kevin Lobo) "While we deli... Full story

Yahoo Finance • 7 days ago

Stock market today: Dow rises, S&P 500 and Nasdaq futures fall as Alphabet stock sells off, AI jitters return

US stock futures diverged in premarket trading on Thursday as Alphabet's Q3 earnings sparked a sell-off in the stock and AI jitters returned to markets, dragging on the tech-heavy indexes. Futures on the Dow Jones Industrial Average (YM=F... Full story

Yahoo Finance • 9 days ago

Stryker (SYK) to report earnings tomorrow: here is what to expect

Stryker (SYK) to report earnings tomorrow: here is what to expect Medical technology company Stryker (NYSE:SYK) will be reporting earnings this Thursday afternoon. Here's what investors should know. Stryker met analysts' revenue expectat... Full story

Yahoo Finance • 14 days ago

Stryker (SYK) Stock May Trade At A Discount Despite FDA Clearance

Stryker has had a mixed run, with the share price up 22.3% over three years but still showing declines over the past year. This puts fresh focus on whether the current US$307.08 level lines up with the cash the business can generate. With... Full story

Yahoo Finance • 22 days ago

Stryker launches Sonopet® 3, delivering greater power and precision in ultrasonic tissue removal

Stryker has received FDA 510(k) clearance for Sonopet® 3 , the latest evolution of its ultrasonic bone and soft tissue removal platform. Developed in collaboration with surgeons, Sonopet 3 delivers enhanced power, precision and versatility... Full story

Yahoo Finance • 25 days ago

Barclays Says MedTech Stocks Are at Their Cheapest in a Decade — and Names 2 Stocks to Buy

Medical technology has been changing human life for centuries. This is especially true for patients dealing with the long-term lifestyle impacts of acute and chronic conditions. Diseases such as diabetes, Crohn's, and cancer, or severe ort... Full story

Yahoo Finance • 27 days ago

Stryker (SYK): Near-Term Growth Concerns Overshadow Long-Term Strength

Mar Vista Investment Partners, LLC, an investment management company, released its third-quarter 2026 investor letter for "Mar Vista U.S. Quality Strategy". The letter can be downloaded here. During the third quarter of 2026, financial mar... Full story

Yahoo Finance • 27 days ago

1 S&P 500 Stock with Solid Fundamentals and 2 We Turn Down

1 S&P 500 Stock with Solid Fundamentals and 2 We Turn Down The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn't mean every stock is worth owning. Some companies face significant challenges, whether it's... Full story

Yahoo Finance • 29 days ago

Stryker (SYK) Stock Could Be Cheap After Its 26% Slide

Stryker has seen its share price slide over the past year, and a planned CEO transition has added a fresh storyline for investors to absorb. The question now is whether the current US$275.40 price tag is aligned with the cash flows the bus... Full story

Yahoo Finance • 30 days ago

Stryker (SYK) vs Boston Scientific (BSX): Which is a Better Stock to Buy?

Stryker Corporation (NYSE:SYK) traded at around $280 on October 6, 22.75% lower over twelve months. Boston Scientific Corporation (NYSE:BSX) traded near $42 over the same session, down 55.79% across the year and within sixty cents of its 5... Full story

Yahoo Finance • 30 days ago

Sector Update: Healthcare Stocks Mixed Late Afternoon

Healthcare stocks were mixed late Tuesday afternoon, with the NYSE Healthcare Index up 0.2% and the PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium... Full story

Yahoo Finance • 30 days ago

Stryker, Neogenomics Announce CEO Transitions; But One Stock Dives

Stryker and Neogenomics stocks diverged Tuesday after the medtech companies announced their chief executives would soon step down. Continue Reading... Full story

Yahoo Finance • last month

3 Large-Cap Stocks Worth Your Attention

3 Large-Cap Stocks Worth Your Attention Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder than for sma... Full story

Yahoo Finance • last month

Moderna, Illumina lead healthcare gains in September as medtech drags

[Close-Up Shot of Scientists Hands typing Data in Laptop in Laboratory] Tom Werner Healthcare stocks underperformed the broader market in September, with the Health Care Select Sector SPDR Fund (XLV [https://seekingalpha.com/symbol/XLV])... Full story

Yahoo Finance • last month

3 AI Healthcare Stocks With Earnings Growth Up To 15%

Runaway demand for AI data centers, highlighted by Nvidia's US$5.7t market cap milestone, shows how quickly capital is chasing tools that can crunch medical data, scan images, and support virtual care at global scale. That same engine is s... Full story

Yahoo Finance • last month

Medical Robots Market Forecasts Growth from $20.6B (2026) to $41.7B by 2031, Profiling Intuitive Surgical, Stryker, Zimmer Biomet & Medtronic

Company Logo The global medical robots market is projected to grow from USD 20.6 billion in 2026 to USD 41.7 billion by 2031, at a 15.1% CAGR. Growth is driven by demand for minimally invasive surgery, healthcare automation, precision pro... Full story

Yahoo Finance • last month

Intuitive Surgical vs. Stryker: Which MedTech Stock Is the Better Buy Now?

Intuitive Surgical ISRG and Stryker SYK offer two distinct paths to robotic-assisted surgery. ISRG is building a focused ecosystem around da Vinci, SP and Ion, while Stryker combines Mako robotics with a broad MedTech portfolio spanning or... Full story

Yahoo Finance • last month

Here's Why You Should Hold Stryker Stock in Your Portfolio for Now

Stryker SYK entered 2026 facing an unexpected cyber disruption, yet underlying demand, robotics adoption and international momentum remained strong. While a robust capital pipeline and active acquisition strategy support long-term growth,... Full story